About this document

Site 975 SI-IC 8021 Main v3.0 - 06mar2026 by aishah.learn is a document available to read on EtoBox.

The AMAZE 1 clinical study, sponsored by Novo Nordisk, investigates the efficacy and safety of the medicine NNC0487-0111 for weight loss in individuals with excess body weight. Participants will receive either the active treatment or a placebo over approximately 2 years and 10 months, with multiple clinic visits and assessments. Informed consent is required, and participants can withdraw at any time without affecting their medical care.

Author

aishah.learn

Language

EN